• About us
• Contact

Advertisement

Organisation › Details

Creoptix Inc.

Creoptix is a company headquartered in Wädenswil, near Zurich, Switzerland, with a US office in the Boston area. Creoptix was founded in 2009 and has successfully gone through several financing rounds with Eduard Brunner from Start Angels Network, Privilège Ventures and Swisscanto (CH) Private Equity Switzerland Growth I Fund, respectively, as lead investors. Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Based on its proprietary sensor and microfluidics technology, the Creoptix® WAVEsystem provides exceptionally high sensitivity and resolution to study real-time biological interactions involving small molecules, peptides, membrane proteins, biologics, and other molecules even in biofluids like undiluted serum or plasma. *

 

	Start	2017-02-06 existent
	Group	Spectris (Group)
	Industry	WAVEsystem (Creoptix)
	Industry 2	waveguide interferometry technology
	Region	Burlington, MA
	Country	United States (USA)
	Street	111 South Bedford Street c/o The Brighton Company, Suite 108
	City	01803 Burlington, MA
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix".
		Record changed: 2023-07-10

Advertisement

More documents for Spectris (Group)

• [1] Malvern Panalytical B.V.. (1/14/22). "Press Release: Malvern Panalytical Inc. and TA Instruments-Waters LLC Agree to Partial Settlement of Patent Infringement Lawsuit". Almelo....
• [2] Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern....
• [3] Creoptix AG. (11/25/20). "Press Release: Creoptix and oneservice Partner for WAVEsystem After-sales Support". Wädenswil (Zurich)....
• [4] Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich)....
• [5] Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich)....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.